USD 0.09
(10.97%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 32.53 Million USD | -19.88% |
2023 | 40.6 Million USD | -8.41% |
2022 | 44.33 Million USD | -7.24% |
2021 | 47.79 Million USD | -10.5% |
2020 | 53.4 Million USD | -14.63% |
2019 | 62.56 Million USD | -2.87% |
2018 | 64.41 Million USD | 80.14% |
2017 | 35.75 Million USD | 17.58% |
2016 | 30.41 Million USD | 4.44% |
2015 | 29.11 Million USD | 6.1% |
2014 | 27.44 Million USD | -7.09% |
2013 | 29.53 Million USD | -6.71% |
2012 | 31.66 Million USD | -3.15% |
2011 | 32.69 Million USD | -0.82% |
2010 | 32.96 Million USD | 1.71% |
2009 | 32.4 Million USD | -0.57% |
2008 | 32.59 Million USD | 82.72% |
2007 | 17.83 Million USD | -8.59% |
2006 | 19.51 Million USD | -4.37% |
2005 | 20.4 Million USD | -0.89% |
2004 | 20.58 Million USD | 21.84% |
2003 | 16.89 Million USD | 3.43% |
2002 | 16.33 Million USD | -2.51% |
2001 | 16.75 Million USD | 10.44% |
2000 | 15.17 Million USD | -5.17% |
1999 | 16 Million USD | 30.08% |
1998 | 12.3 Million USD | 20.59% |
1997 | 10.2 Million USD | 50.0% |
1996 | 6.8 Million USD | 11.48% |
1995 | 6.1 Million USD | 24.49% |
1994 | 4.9 Million USD | -18.33% |
1993 | 6 Million USD | -9.09% |
1992 | 6.6 Million USD | 4.76% |
1991 | 6.3 Million USD | -4.55% |
1990 | 6.6 Million USD | -10.81% |
1989 | 7.4 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 9.35 Million USD | 10.83% |
2024 Q3 | 7.65 Million USD | -6.05% |
2024 Q4 | 7.37 Million USD | -3.72% |
2024 Q2 | 8.15 Million USD | -12.84% |
2023 Q1 | 12.05 Million USD | 7.7% |
2023 FY | 40.6 Million USD | -8.41% |
2023 Q2 | 10.88 Million USD | -9.71% |
2023 Q3 | 9.23 Million USD | -15.14% |
2023 Q4 | 8.43 Million USD | -8.63% |
2022 FY | 44.33 Million USD | -7.24% |
2022 Q1 | 12.3 Million USD | 0.51% |
2022 Q2 | 10.52 Million USD | -14.4% |
2022 Q3 | 10.31 Million USD | -2.03% |
2022 Q4 | 11.19 Million USD | 8.48% |
2021 FY | 47.79 Million USD | -10.5% |
2021 Q1 | 12.13 Million USD | 49.49% |
2021 Q2 | 11.96 Million USD | -1.36% |
2021 Q3 | 11.46 Million USD | -4.24% |
2021 Q4 | 12.23 Million USD | 6.78% |
2020 Q3 | 13.7 Million USD | -9.81% |
2020 Q1 | 16.38 Million USD | 5.68% |
2020 Q2 | 15.19 Million USD | -7.28% |
2020 FY | 53.4 Million USD | -14.63% |
2020 Q4 | 8.11 Million USD | -40.79% |
2019 Q3 | 14.55 Million USD | -5.75% |
2019 Q4 | 15.5 Million USD | 6.57% |
2019 FY | 62.56 Million USD | -2.87% |
2019 Q1 | 17.06 Million USD | 0.97% |
2019 Q2 | 15.43 Million USD | -9.53% |
2018 Q3 | 16.63 Million USD | -8.0% |
2018 Q4 | 16.9 Million USD | 1.61% |
2018 FY | 64.41 Million USD | 80.14% |
2018 Q1 | 12.79 Million USD | 14.61% |
2018 Q2 | 18.08 Million USD | 41.28% |
2017 FY | 35.75 Million USD | 17.58% |
2017 Q4 | 11.16 Million USD | 44.72% |
2017 Q3 | 7.71 Million USD | -11.45% |
2017 Q1 | 8.16 Million USD | 0.39% |
2017 Q2 | 8.71 Million USD | 6.75% |
2016 FY | 30.41 Million USD | 4.44% |
2016 Q4 | 8.13 Million USD | 9.74% |
2016 Q3 | 7.4 Million USD | -0.88% |
2016 Q2 | 7.47 Million USD | 1.05% |
2016 Q1 | 7.39 Million USD | -6.45% |
2015 Q3 | 6.69 Million USD | -8.39% |
2015 FY | 29.11 Million USD | 6.1% |
2015 Q1 | 7.21 Million USD | 2.27% |
2015 Q2 | 7.3 Million USD | 1.2% |
2015 Q4 | 7.9 Million USD | 18.18% |
2014 Q3 | 6.18 Million USD | -13.45% |
2014 FY | 27.44 Million USD | -7.09% |
2014 Q4 | 7.05 Million USD | 14.08% |
2014 Q1 | 7.05 Million USD | -2.87% |
2014 Q2 | 7.14 Million USD | 1.29% |
2013 FY | 29.53 Million USD | -6.71% |
2013 Q4 | 7.26 Million USD | 2.73% |
2013 Q3 | 7.07 Million USD | -11.6% |
2013 Q2 | 7.99 Million USD | 10.99% |
2013 Q1 | 7.2 Million USD | -6.88% |
2012 Q3 | 7.65 Million USD | -7.51% |
2012 Q4 | 7.73 Million USD | 1.11% |
2012 FY | 31.66 Million USD | -3.15% |
2012 Q1 | 7.99 Million USD | -2.36% |
2012 Q2 | 8.27 Million USD | 3.48% |
2011 Q1 | 7.91 Million USD | -0.3% |
2011 Q2 | 8.19 Million USD | 3.54% |
2011 Q4 | 8.19 Million USD | -2.31% |
2011 Q3 | 8.38 Million USD | 2.25% |
2011 FY | 32.69 Million USD | -0.82% |
2010 Q1 | 8.28 Million USD | 2.78% |
2010 Q3 | 8.23 Million USD | -3.13% |
2010 Q4 | 7.94 Million USD | -3.54% |
2010 Q2 | 8.5 Million USD | 2.64% |
2010 FY | 32.96 Million USD | 1.71% |
2009 Q3 | 7.63 Million USD | -12.45% |
2009 Q1 | 7.99 Million USD | -0.76% |
2009 Q2 | 8.71 Million USD | 9.04% |
2009 FY | 32.4 Million USD | -0.57% |
2009 Q4 | 8.05 Million USD | 5.57% |
2008 Q1 | 7.89 Million USD | 59.76% |
2008 Q2 | 8.86 Million USD | 12.29% |
2008 Q3 | 7.78 Million USD | -12.18% |
2008 Q4 | 8.05 Million USD | 3.54% |
2008 FY | 32.59 Million USD | 82.72% |
2007 FY | 17.83 Million USD | -8.59% |
2007 Q3 | 4.33 Million USD | -2.21% |
2007 Q1 | 4.13 Million USD | -16.28% |
2007 Q2 | 4.42 Million USD | 6.99% |
2007 Q4 | 4.93 Million USD | 14.06% |
2006 FY | 19.51 Million USD | -4.37% |
2006 Q4 | 4.94 Million USD | -0.71% |
2006 Q3 | 4.97 Million USD | -4.8% |
2006 Q2 | 5.23 Million USD | 20.02% |
2006 Q1 | 4.35 Million USD | -14.79% |
2005 Q4 | 5.11 Million USD | 1.32% |
2005 Q3 | 5.04 Million USD | -5.16% |
2005 FY | 20.4 Million USD | -0.89% |
2005 Q1 | 4.91 Million USD | -2.1% |
2005 Q2 | 5.32 Million USD | 8.21% |
2004 Q4 | 5.02 Million USD | -4.23% |
2004 Q2 | 5.28 Million USD | 4.97% |
2004 Q3 | 5.24 Million USD | -0.71% |
2004 FY | 20.58 Million USD | 21.84% |
2004 Q1 | 5.03 Million USD | 12.03% |
2003 FY | 16.89 Million USD | 3.43% |
2003 Q2 | 4.12 Million USD | 0.23% |
2003 Q1 | 4.11 Million USD | 1.51% |
2003 Q4 | 4.49 Million USD | 7.92% |
2003 Q3 | 4.16 Million USD | 0.93% |
2002 Q3 | 4.15 Million USD | 5.13% |
2002 FY | 16.33 Million USD | -2.51% |
2002 Q4 | 4.05 Million USD | -2.52% |
2002 Q2 | 3.95 Million USD | -5.06% |
2002 Q1 | 4.16 Million USD | -1.39% |
2001 Q2 | 4.04 Million USD | -0.47% |
2001 Q3 | 4.41 Million USD | 9.14% |
2001 Q4 | 4.22 Million USD | -4.34% |
2001 FY | 16.75 Million USD | 10.44% |
2001 Q1 | 4.06 Million USD | -10.11% |
2000 Q2 | 3.4 Million USD | -2.86% |
2000 Q3 | 3.75 Million USD | 10.49% |
2000 FY | 15.17 Million USD | -5.17% |
2000 Q1 | 3.5 Million USD | -5.41% |
2000 Q4 | 4.52 Million USD | 20.42% |
1999 Q2 | 4 Million USD | -18.37% |
1999 Q4 | 3.7 Million USD | 8.82% |
1999 FY | 16 Million USD | 30.08% |
1999 Q1 | 4.9 Million USD | 48.48% |
1999 Q3 | 3.4 Million USD | -15.0% |
1998 Q3 | 3 Million USD | 0.0% |
1998 FY | 12.3 Million USD | 20.59% |
1998 Q1 | 3 Million USD | 0.0% |
1998 Q2 | 3 Million USD | 0.0% |
1998 Q4 | 3.3 Million USD | 10.0% |
1997 Q4 | 3 Million USD | 20.0% |
1997 Q3 | 2.5 Million USD | 13.64% |
1997 Q1 | 2.4 Million USD | 33.33% |
1997 Q2 | 2.2 Million USD | -8.33% |
1997 FY | 10.2 Million USD | 50.0% |
1996 FY | 6.8 Million USD | 11.48% |
1996 Q4 | 1.8 Million USD | 12.5% |
1996 Q3 | 1.6 Million USD | -20.0% |
1996 Q2 | 2 Million USD | 53.85% |
1996 Q1 | 1.3 Million USD | -7.14% |
1995 FY | 6.1 Million USD | 24.49% |
1995 Q3 | 1.4 Million USD | -6.67% |
1995 Q2 | 1.5 Million USD | -16.67% |
1995 Q1 | 1.8 Million USD | 50.0% |
1995 Q4 | 1.4 Million USD | 0.0% |
1994 Q2 | 1.2 Million USD | 0.0% |
1994 Q1 | 1.2 Million USD | -29.41% |
1994 FY | 4.9 Million USD | -18.33% |
1994 Q4 | 1.2 Million USD | -7.69% |
1994 Q3 | 1.3 Million USD | 8.33% |
1993 Q4 | 1.7 Million USD | -10.53% |
1993 Q1 | 1.3 Million USD | -18.75% |
1993 FY | 6 Million USD | -9.09% |
1993 Q2 | 1.1 Million USD | -15.38% |
1993 Q3 | 1.9 Million USD | 72.73% |
1992 Q3 | 1.7 Million USD | 0.0% |
1992 Q2 | 1.7 Million USD | 13.33% |
1992 Q1 | 1.5 Million USD | -11.76% |
1992 Q4 | 1.6 Million USD | -5.88% |
1992 FY | 6.6 Million USD | 4.76% |
1991 Q2 | 1.4 Million USD | -12.5% |
1991 Q1 | 1.6 Million USD | 6.67% |
1991 Q4 | 1.7 Million USD | 0.0% |
1991 Q3 | 1.7 Million USD | 21.43% |
1991 FY | 6.3 Million USD | -4.55% |
1990 Q2 | 1.6 Million USD | 6.67% |
1990 Q4 | 1.5 Million USD | -16.67% |
1990 FY | 6.6 Million USD | -10.81% |
1990 Q1 | 1.5 Million USD | -25.0% |
1990 Q3 | 1.8 Million USD | 12.5% |
1989 Q1 | 1.5 Million USD | 0.0% |
1989 Q2 | 1.8 Million USD | 20.0% |
1989 FY | 7.4 Million USD | 0.0% |
1989 Q4 | 2 Million USD | -4.76% |
1989 Q3 | 2.1 Million USD | 16.67% |
Name | Revenue | Revenue Difference |
---|---|---|
Acutus Medical, Inc. | 7.16 Million USD | -354.131% |
Biotricity, Inc. | 12.06 Million USD | -169.693% |
Cell MedX Corp. | - USD | -Infinity% |
Nemaura Medical Inc. | 77.04 Thousand USD | -42127.772% |
PetVivo Holdings, Inc. | 968.7 Thousand USD | -3258.497% |
RetinalGenix Technologies Inc. | - USD | -Infinity% |
Sonendo, Inc. | 43.86 Million USD | 25.832% |
Telesis Bio, Inc. | 27.5 Million USD | -18.267% |
Talis Biomedical Corporation | 412 Thousand USD | -7796.593% |
Viveve Medical, Inc. | 6.42 Million USD | -406.286% |